Allan Brown
Directeur Général chez Glycoscoredx Ltd.
Profil
Allan Brown is currently the Chief Executive Officer at Glycoscoredx Ltd.
Prior to this, he worked as an Executive Director & COO-Diagnostics Division at Genedrive Plc from 2015 to 2017.
He also worked as a Divisional Managing Director at Hologic Ltd.
Postes actifs de Allan Brown
| Sociétés | Poste | Début |
|---|---|---|
Glycoscoredx Ltd.
 Glycoscoredx Ltd. Miscellaneous Commercial ServicesCommercial Services Glycoscoredx Ltd. develops a novel blood test that revolutionizes how prostate cancer is diagnosed. The company is based in Newcastle upon Tyne, UK. The British company was founded in 2020 by Jennifer Munkley. Allan Brown has been the CEO of the company since 2020. | Directeur Général | 01/09/2020 |
Anciens postes connus de Allan Brown
| Sociétés | Poste | Fin |
|---|---|---|
| GENEDRIVE PLC | Directeur des opérations | 08/11/2017 |
Hologic Ltd.
 Hologic Ltd. Medical SpecialtiesHealth Technology Hologic Ltd. manufactures life sciences products and services with two divisions, Molecular Diagnostics and Research Products & Services. The firm has laboratories, manufacturing and operations in the USA, UK and France. It provides test kits, reagents and services to two synergistic markets. It focuses on these niche opportunities with products, patents, expertise and acquisitions. The company was founded in 1992 and is headquartered in Wythenshawe, the United Kingdom. | Corporate Officer/Principal | 01/01/2010 |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| GENEDRIVE PLC | Health Technology |
| Entreprise privées | 2 |
|---|---|
Hologic Ltd.
Hologic Ltd. Medical SpecialtiesHealth Technology Hologic Ltd. manufactures life sciences products and services with two divisions, Molecular Diagnostics and Research Products & Services. The firm has laboratories, manufacturing and operations in the USA, UK and France. It provides test kits, reagents and services to two synergistic markets. It focuses on these niche opportunities with products, patents, expertise and acquisitions. The company was founded in 1992 and is headquartered in Wythenshawe, the United Kingdom. | Health Technology |
Glycoscoredx Ltd.
Glycoscoredx Ltd. Miscellaneous Commercial ServicesCommercial Services Glycoscoredx Ltd. develops a novel blood test that revolutionizes how prostate cancer is diagnosed. The company is based in Newcastle upon Tyne, UK. The British company was founded in 2020 by Jennifer Munkley. Allan Brown has been the CEO of the company since 2020. | Commercial Services |